4 studies on Hypothalamic pituitary axis mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**Clinicians managing TBI or SAH survivors should consider routine GH axis screening**, as hypopituitarism and aGHD are far more prevalent in this population than traditionally assumed. The **GHRP-2 test's <9 ng/mL cu…
**Clinicians and researchers testing GH-axis function must control for age, estrogen status, and visceral fat simultaneously** — failing to account for any single factor can produce spurious group differences in secre…
**Clinicians and peptide users designing GH-stimulation protocols in women must account for menopausal status and concurrent estrogen exposure, not just dosing of the secretagogue itself.** The finding that GHRP-2 out…
**Stacking GHRH with a GHS like MK-677 may not linearly amplify hypothalamic activation** — endogenous GH released by either agent appears to dampen arcuate responsiveness through a shared feedback ceiling, explaining…